Monday, April 1, 2019

Researchers optimize gene editing for SCD and beta thalassemia

Gene editing of patients' blood stem cells can potentially cure many blood disorders. But introducing targeted edits into these cells has been challenging, and the edits aren't always stable once the cells engraft in the bone marrow. Researchers now report a CRISPR approach that overcomes these technical challenges.

from Top Health News -- ScienceDaily https://ift.tt/2VcPfvS

No comments:

Post a Comment

Common plastic chemical linked to lifelong anxiety in new study

Exposure to a common plastic chemical before and shortly after birth may have lasting effects on behavior. Researchers found that male rats ...